ONC
Price:
$323.01
Market Cap:
$43.55B
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its clinical stage products com...[Read more]
Industry
Biotechnology
IPO Date
2016-02-03
Stock Exchange
NASDAQ
Ticker
ONC
According to BeOne Medicines AG’s latest financial reports and current stock price. The company's current PE Ratio is 72.26. This represents a change of 8.24% compared to the average of 66.76 of the last 4 quarters.
The mean historical PE Ratio of BeOne Medicines AG over the last ten years is 15.27. The current 72.26 PE Ratio has changed 47.22% with respect to the historical average. Over the past ten years (40 quarters), ONC's PE Ratio was at its highest in in the March 2025 quarter at 691.23. The PE Ratio was at its lowest in in the June 2016 quarter at -8.29.
Average
15.27
Median
-1.69
Minimum
-11.09
Maximum
182.85
Discovering the peaks and valleys of BeOne Medicines AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 135.25%
Maximum Annual PE Ratio = 182.85
Minimum Annual Increase = -5174.33%
Minimum Annual PE Ratio = -11.09
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 182.85 | -5174.33% |
| 2024 | -3.60 | 55.06% |
| 2023 | -2.32 | 135.25% |
| 2022 | -0.99 | -31.77% |
| 2021 | -1.45 | 14.29% |
| 2020 | -1.27 | -13.42% |
| 2019 | -1.46 | -24.05% |
| 2018 | -1.93 | -82.63% |
| 2017 | -11.09 | 83.68% |
| 2016 | -6.04 | 63.39% |
The current PE Ratio of BeOne Medicines AG (ONC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
58.98
5-year avg
34.90
10-year avg
15.27
BeOne Medicines AG’s PE Ratio is greater than Humana Inc. (34.01), greater than Insmed Incorporated (-17.17), greater than GE HealthCare Technologies Inc. (20.19), greater than ResMed Inc. (21.50), greater than IQVIA Holdings Inc. (28.07), greater than Alcon Inc. (42.77), greater than Mettler-Toledo International Inc. (32.26), greater than Natera, Inc. (-168.83), greater than Koninklijke Philips N.V. (19.67), greater than Agilent Technologies, Inc. (27.90),
| Company | PE Ratio | Market cap |
|---|---|---|
| 34.01 | $43.48B | |
| -17.17 | $21.40B | |
| 20.19 | $31.74B | |
| 21.50 | $32.37B | |
| 28.07 | $37.56B | |
| 42.77 | $34.62B | |
| 32.26 | $29.04B | |
| -168.83 | $39.41B | |
| 19.67 | $25.87B | |
| 27.90 | $39.31B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeOne Medicines AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BeOne Medicines AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BeOne Medicines AG's PE Ratio?
How is the PE Ratio calculated for BeOne Medicines AG (ONC)?
What is the highest PE Ratio for BeOne Medicines AG (ONC)?
What is the 3-year average PE Ratio for BeOne Medicines AG (ONC)?
What is the 5-year average PE Ratio for BeOne Medicines AG (ONC)?
How does the current PE Ratio for BeOne Medicines AG (ONC) compare to its historical average?